换一批Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report.
第一作者：
M S,Cairo
第一单位：
Babies and Children's Hospital, Columbia University, New York, New York, USA. MC1310@columbia.edu
作者：
医学主题词
青少年(Adolescent);成年人(Adult);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);卡铂(Carboplatin);儿童(Child);儿童, 学龄前(Child, Preschool);剂量效应关系, 药物(Dose-Response Relationship, Drug);依托泊甙(Etoposide);女(雌)性(Female);粒细胞集落刺激因子(Granulocyte Colony-Stimulating Factor);人类(Humans);异环磷酰胺(Ifosfamide);婴儿(Infant);白细胞计数(Leukocyte Count);男(雄)性(Male);肿瘤(Neoplasms);中性粒细胞减少(Neutropenia);中性白细胞(Neutrophils);前瞻性研究(Prospective Studies);重组蛋白质类(Recombinant Proteins);复发(Recurrence);存活率(Survival Rate);时间因素(Time Factors);美国(United States)
DOI
10.1097/00043426-200101000-00008
PMID
11196267
发布时间
2021-12-03
基金项目
R25 CA092049/CA/NCI NIH HHS/United States
- 浏览42
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
